Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Clinigen Group Plc LSE:CLIN London Ordinary Share GB00B89J2419 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -7.00 -1.1% 631.50 633.00 635.00 660.00 620.00 660.00 599,255 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 504.3 22.6 10.3 61.3 839

Clinigen Share Discussion Threads

Showing 1151 to 1174 of 1225 messages
Chat Pages: 49  48  47  46  45  44  43  42  41  40  39  38  Older
DateSubjectAuthorDiscuss
09/6/2021
09:52
600p is the obvious target here. How close will we get?
its the oxman
09/6/2021
09:36
What did they miss EBIDTA estimates by? "now expected that adjusted EBITDA 2 will be within the range of £114m-£117m for the full year 2021" Edit. MarketScreener had estimated £131.
theprovosts
09/6/2021
09:36
Buyer at 600
nw99
09/6/2021
08:40
averaged down - fingers crossed. I think 20%+ is a bit overdone.
johnrxx99
09/6/2021
08:39
I see this as a temporary blip and a buying opportunity for a solid companyI'll be topping up when the dust settles.
r2oo
09/6/2021
08:23
Not really
robertball
09/6/2021
08:22
Temporary weakness...
bulltradept
04/6/2021
17:24
Anyone have views on Iovance and their TIL product? Things don’t look good as fda knocked back assays again.
whatja
04/6/2021
16:26
Looks undervalued in a growth sector. <1 PEG of next 2 years and low PE and reasonable EV/EBITDA of 11. My kind of stock.
johnrxx99
04/6/2021
13:00
Because there is not much to debate... There have been some small contracts announced but There needs to be news about Proleukin and Erwinase. I would have thought the offer for UDG would create a ripple here as it has some similar business. What do you think of the share Johnr?
whatja
04/6/2021
09:52
Why so nice and quiet?
johnrxx99
24/2/2021
22:59
Hi All, a new article on Clinigen uploaded to my website. Analysis of the half year report and financials. hxxps://www.thetwentiestrader.com/post/clinigen-cash-not-clarity
thetwentiestrader
24/2/2021
11:53
Yes, I think the share price is factoring in that level of debt being permanent and the company not managing to reduce it this calendar year to the 1x-2x range which they've been talking about for a while now.
adamb1978
24/2/2021
10:26
Investor's Champion comments: Net debt of £351.5m looks quite high to us but leverage is expected to reduce significantly over the course of this year. It is also worth emphasising that Clinigen has not participated in any government funding scheme relating to the pandemic and has also been able to maintain an interim dividend of 2.15p.
energeticbacker
23/2/2021
13:04
Hi Cellars Yes, I had a look through the results this morning, but need a closer look later. Gut feel was that they were what I was expecting with a slight positive comment about current year growth Market forecasts are for 63p EPS this year growing to 87p in FY23 and I think those figures are very achievable. On that basis, I think £10-£12 share price is eminently achievable within a couple years. The de-gearing over the course of this year I think will help move the share price along, along with the general achievement of results. Adam
adamb1978
09/2/2021
11:27
Private equity?
mellorscarthwaite
09/2/2021
11:17
There have been regular 3% and more gains recently as it has gone from 700 to 800 The trading update was useful but there has been limited news to drive the price. Next formal update will be HY reporting in March.
whatja
30/1/2021
13:38
Just for some assistance in support levels and resistance levels.
badg
29/1/2021
15:06
Why a charter......up 3% in a market down 2% is remarkable. Not sure why this would happen now but it looks good for better times ahead.
whatja
28/1/2021
17:08
It's a slog but we seem to be getting somewhere...Chartists views would be appreciated
badg
15/1/2021
08:37
BADG I wouldnt read much into it at all. Might just be wanting to get people to understand the change in reporting structure before the results come out. A FTSE100 company did similarly about 6 mos ago (cant remember which one) and it looked a little over the top in terms of disclosure but being more open rather than less is probably good Market did seem to like/accept the TU yesterday. Relief for me given that its the last one before debt start to reduce and growth narrative starts to improve. I'm hopefully that we'll therefore see a gradual grind up from £7 towards £10 over the next 12-18 mos. Adam
adamb1978
14/1/2021
22:42
I am just wondering why the need to:"The Group expects to publish its results for the six months ended 31 December 2020 on Tuesday 23 February 2021 and ahead of this, Clinigen will issue a reconciliation showing how recent historic trading would have been reported on the new two divisional basis."Probably being thick but why the need to do this?! Maybe some sort of base line so as not to shock the market with the new system of reporting?I was very nervous this morning when the market opened - quite large swings but seemed to settle into a nice rise after having bounced off the 200 MA again....
badg
14/1/2021
21:14
Market seemed to warm to the extensive update. Set itself up for a big H2...
whatja
12/1/2021
18:51
Ouch.. not a good day - am just hoping it will sit on the 200MA ?
badg
Chat Pages: 49  48  47  46  45  44  43  42  41  40  39  38  Older
ADVFN Advertorial
Your Recent History
LSE
CLIN
Clinigen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210619 21:15:13